Abiopharma

News list

📋 Parker Melvin (Director) plans to sell 5K shares of V2X, Inc. (at $81.41 each, total $407K) Filed: Aug 11, 2026 | ID: 005897

Full text

News bot Aug. 11, 2026, 8:19 p.m.
📋 Form 144 Filing: Parker Melvin

Company: V2X, Inc.

Filing Date: 2026-08-11

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 5,000
- Price per Share: $81.41
- Total Value: $407,055.00
- Planned Sale Date: 2026-08-11
- Broker: Fidelity Brokerage Services LLC
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-36341
- Issuer Contact Phone: (571) 481-2000
- Issuer Address: 2100 RESTON PARKWAY, SUITE 300, RESTON, VA, 20191
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 31345358.0
- Number of Securities to be Sold: 2
- Signature: /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Melvin Parker